The definitive 24-week Phase III trial in 534 obese participants, testing doses of 0.25mg, 0.5mg and 1.0mg daily, did not produce statistically significant weight loss over placebo
Overweight plus a related condition A BMI of 27 kg/m or greater with a weight-related condition such as hypertension, dyslipidemia, sleep apnea, cardiovascular disease, or type 2 diabetes
Theres no guessing and no pressure
References: [1] pmc/articles/PMC6271067/ [2] science/article/abs/pii/S00219673 12014550 [3] TB500 BPC157 20mg Pre Mixed Pen Blended Peptide Specifications: BPC-157: Sequence : Gly- Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ma Asp-Asp Ala Gly Leu Val Molecular Formula: C62H98N16O22 Molecular Weight: 1419.556 For additional insights on BPC-157 Peptide, visit our dedicated BPC-157 page, which provides a thorough overview of research studies, scientific data, certificates of analysis, and the various forms of the peptide available that Direct Peptides offers for purchase
Pairing, Safety and Status Why is Ipamorelin combined with CJC-1295 or Tesamorelin
Nature 460 , 473478 (2009)